HUM Stock Overview
Provides medical and specialty insurance products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Humana Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$281.40 |
| 52 Week High | US$469.50 |
| 52 Week Low | US$191.00 |
| Beta | 0.52 |
| 11 Month Change | 18.33% |
| 3 Month Change | -10.52% |
| 1 Year Change | -40.06% |
| 33 Year Change | -26.93% |
| 5 Year Change | -9.23% |
| Change since IPO | 2,658.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| HUM | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 8.6% | 1.1% | 0.2% |
| 1Y | -40.1% | 16.5% | 8.5% |
Return vs Industry: HUM underperformed the German Healthcare industry which returned 16.5% over the past year.
Return vs Market: HUM underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| HUM volatility | |
|---|---|
| HUM Average Weekly Movement | 8.7% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: HUM's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: HUM's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 67,600 | Jim Rechtin | www.humana.com |
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals.
Humana Inc. Fundamentals Summary
| HUM fundamental statistics | |
|---|---|
| Market cap | €34.47b |
| Earnings (TTM) | €1.31b |
| Revenue (TTM) | €110.44b |
26.4x
P/E Ratio0.3x
P/S RatioIs HUM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HUM income statement (TTM) | |
|---|---|
| Revenue | US$115.01b |
| Cost of Revenue | US$98.07b |
| Gross Profit | US$16.95b |
| Other Expenses | US$15.59b |
| Earnings | US$1.36b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 29, 2025
| Earnings per share (EPS) | 11.29 |
| Gross Margin | 14.73% |
| Net Profit Margin | 1.18% |
| Debt/Equity Ratio | 75.9% |
How did HUM perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield32%
Payout RatioDoes HUM pay a reliable dividends?
See HUM dividend history and benchmarks| Humana dividend dates | |
|---|---|
| Ex Dividend Date | Dec 31 2024 |
| Dividend Pay Date | Jan 31 2025 |
| Days until Ex dividend | 35 days |
| Days until Dividend pay date | 66 days |
Does HUM pay a reliable dividends?
See HUM dividend history and benchmarks